Workflow
Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program
TMX Newsfile· 2025-12-18 21:05
Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced telomere analytics, today announced the initiation of a new multiple myeloma (MM) Minimal Residual Disease (MRD) clinical trial in collaboration with the University of Athens. This retrospective study is a key component of Telo's expanding, multi-center MRD validation program and is designed to evaluate the clin ...
GSP Resource Corp. Closes Private Placement of Flow-Through Shares
Thenewswire· 2025-12-18 21:05
Not for distribution to United States Newswire Services or for dissemination in the United StatesVancouver, British Columbia – TheNewswire - December 18, 2025: GSP Resource Corp. (TSX-V: GSPR) (the “Company” or “GSP”) announces that it has closed a non-brokered private placement (the “Private Placement”), consisting of 2,000,000 flow-through shares (each, a “FT Share”) at a price of $0.12 per FT share for aggregate gross proceeds of $240,000. Each FT Share constitutes a “flow-through share” within the mean ...
Burke & Herbert Financial Services Corp. and LINKBANCORP, Inc. Announce Agreement to Merge
Prnewswire· 2025-12-18 21:05
ALEXANDRIA, Va. and CAMP HILL, Pa., Dec. 18, 2025 /PRNewswire/ -- Burke & Herbert Financial Services Corp. (the "Company" or "Burke & Herbert") (Nasdaq: BHRB) and LINKBANCORP, Inc. ("LINK") (Nasdaq: LNKB), the parent company of LINKBANK, today announced the signing of a definitive merger agreement pursuant to which Burke & Herbert will acquire LINK in an all-stock transaction valued at approximately $354.2 million or $9.38 per share of LINK common stock, based on a closing price for Burke & Herbert's common ...
NANO Nuclear Reports Fiscal Year 2025 Financial Results and Provides Business Update
Globenewswire· 2025-12-18 21:05
NANO Nuclear Energy Inc. NANO Nuclear Reports Fiscal Year 2025 Financial Results and Provides Business Update Management to hold webcast today at 5:00 pm Eastern New York, N.Y., Dec. 18, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor and technology company focused on developing clean energy solutions, today reported its fiscal year 2025 financial results and provided a business update. Figure 1 - NANO N ...
Cars Commerce Names Tobias Hartmann as Next Chief Executive Officer, Succeeding CEO Alex Vetter Effective January 15, 2026
Prnewswire· 2025-12-18 21:05
Core Viewpoint - Cars.com Inc. has announced the appointment of Tobias Hartmann as the new CEO, effective January 15, 2026, succeeding Alex Vetter, who will step down from his role and serve as an advisor until March 31, 2026 [1][2]. Company Leadership Transition - Tobias Hartmann brings over 25 years of experience in B2C and B2B technology, eCommerce, and marketplace companies, having previously served as CEO of Scout24 SE Group and President of HelloFresh SE [2][3]. - Alex Vetter has been with Cars.com since its inception in 1998 and has played a crucial role in transforming the company into a vertical SaaS platform for the automotive industry [3][4]. Strategic Vision - Hartmann aims to leverage digital tools, data, and AI to enhance customer competitiveness in the automotive retail and wholesale sectors [3]. - The Board of Directors expressed confidence in Hartmann's ability to accelerate growth and guide the company into the future [3][4]. Company Background - Cars Commerce is a technology company focused on empowering the automotive industry through innovative solutions and AI-driven technologies that enhance car buying and selling processes [5][6]. - The platform includes various brands such as Cars.com, Dealer Inspire, AccuTrade, DealerClub, and Cars Commerce Media Network, which collectively support efficient and profitable retail operations [6].
Mission Produce® Announces Leadership Succession and Provides Update on Board Refreshment Initiative
Globenewswire· 2025-12-18 21:05
Founder & CEO Steve Barnard to Transition to Executive Chairman of the Board; President and COO John Pawlowski to Become CEO at the close of the Annual Meeting of Shareholders in April 2026 Board Refreshment Initiative Underway –Three New Independent Directors Appointed in Advance of Expected Retirement of Current Board Chair at close of the Annual Meeting OXNARD, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” or “the Company”) a world leader in sourcing, producing, ...
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson's Disease
Globenewswire· 2025-12-18 21:05
BETHESDA, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that it will host a virtual key opinion leader (KOL) event, “Understanding GCase Substrates in Parkinson’s Disease: Perspectives on Biomarkers and Disease Modification, Contextualizing emerging biomarker data from the Phase 1b clinical stud ...
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Globenewswire· 2025-12-18 21:05
Core Viewpoint - Medline Inc. has successfully completed its upsized initial public offering (IPO) of 248,439,654 shares of Class A common stock at a price of $29.00 per share, including the underwriters' option to purchase an additional 32,405,172 shares [1] Group 1: IPO Details - The proceeds from the issuance of 179,000,000 shares will be used to repay outstanding indebtedness under senior secured term loan facilities, with the remainder allocated for general corporate purposes and offering expenses [2] - Medline plans to use proceeds from the issuance of 37,034,482 shares and the additional shares purchased by underwriters to buy or redeem an equivalent number of outstanding equity interests from certain pre-IPO owners [2] - The Class A common stock of Medline is listed on the Nasdaq Global Select Market under the symbol "MDLN" [2] Group 2: Underwriters and Managers - Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan acted as global coordinators and lead bookrunning managers for the offering [2] - A wide range of firms, including Barclays, Citigroup, and Deutsche Bank Securities, served as bookrunning managers, while numerous others acted as co-managers for the offering [2] Group 3: Company Overview - Medline is the largest provider of medical-surgical products and supply chain solutions, serving all points of care [5] - The company has a broad product portfolio, resilient supply chain, and leading clinical solutions aimed at improving clinical, financial, and operational outcomes for healthcare providers [5] - Headquartered in Northfield, Illinois, Medline employs over 43,000 people globally and operates in more than 100 countries [5]
Parsons Names John Martinez as the Company's Next Chief Legal Officer
Globenewswire· 2025-12-18 21:05
CHANTILLY, Va., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE:PSN) has named proven executive and legal expert John Martinez as the company’s next chief legal officer (CLO), effective February 16, 2026. The announcement follows the notification by current CLO Mike Kolloway to Parsons’ CEO and board of directors of his intent to retire in the second quarter of 2026; Kolloway will remain with the company as an advisor until his retirement to ensure a seamless transition. “John Martinez is one of ...
Safe Harbor Financial Statement on Federal Cannabis Rescheduling and the Resulting Growth Opportunity for Its Banking Platform
Globenewswire· 2025-12-18 21:05
Improved operator economics and expanding institutional interest position Safe Harbor for scalable, compliant growthDENVER, Dec. 18, 2025 (GLOBE NEWSWIRE) -- SHF Holdings, Inc., d/b/a Safe Harbor Financial (NASDAQ: SHFS) (“Safe Harbor” or the “Company”), a provider of banking, lending, and financial services to the legal cannabis industry, announced that the federal rescheduling of cannabis represents a meaningful policy shift with long-term implications for the Company’s platform. The reclassification is e ...